P
Pauline Brice
Researcher at University of Paris
Publications - 243
Citations - 14207
Pauline Brice is an academic researcher from University of Paris. The author has contributed to research in topics: Brentuximab vedotin & Follicular lymphoma. The author has an hindex of 56, co-authored 227 publications receiving 12729 citations.
Papers
More filters
Journal ArticleDOI
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
Franck Morschhauser,Loretta J. Nastoupil,Pierre Feugier,Jean-Marc Schiano de Colella,Hervé Tilly,M. Lia Palomba,Emmanuel Bachy,Christophe Fruchart,Edward N. Libby,Rene-Olivier Casasnovas,Ian W. Flinn,Corinne Haioun,Hervé Maisonneuve,Loic Ysebaert,Nancy L. Bartlett,R. Bouabdallah,Pauline Brice,Vincent Ribrag,Steven Le Gouill,Nicolas Daguindau,Stéphanie Guidez,Gianmatteo Pica,Alejandro Martin Garcia-Sancho,Armondo López-Guillermo,Jean-François Larouche,Kiyoshi Ando,Maria Gomes da Silva,Marc André,Wu Kalung,Laurie H. Sehn,Koji Izutsu,Guillaume Cartron,Argyrios Gkasiamis,Russell Crowe,Luc Xerri,Nathan Fowler,Gilles Salles +36 more
TL;DR: R2 continues to demonstrate comparable, durable efficacy and safety versus R-chemo in previously untreated patients with FL and provides an acceptable chemo-free alternative.
Journal ArticleDOI
Hodgkin Variant of Richter's Syndrome: Report of 34 Cases. A Role of EBV in Transformation.
Bénédicte Deau,Caroline Bonmati,Emmanuel Bachy,Xavier Carles,Pauline Brice,Franck Morschhauser,Philippe Rousselot,Marie-Olivia Chandesris,Richard Delarue,Bruno Varet,Vincent Ribrag,Olivier Hermine +11 more
TL;DR: Patients with the Hodgkin variant of Richter's syndrome generally present with a more advanced stage of disease than do patients with de novo Hodgkin disease, and the rates of response and survival in patients with this variant were inferior to those reported in patientsWith de noVO Hodgkin lymphoma, but better than those with classic Richter’s syndrome.
Journal ArticleDOI
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson,Marie Beylot-Barry,Caroline Ram-Wolff,Jean-Baptiste Mear,Stéphane Dalle,Michel D'Incan,Saskia Ingen-Housz-Oro,Corentin Orvain,Julie Abraham,Olivier Dereure,Amandine Charbonnier,Jérôme Cornillon,Christine Longvert,Stéphane Barete,Serge Boulinguez,E. Wierzbicka-Hainaut,François Aubin,Marie-Thérèse Rubio,M. Bernard,Aline Schmidt-Tanguy,Roch Houot,Anne Pham-Ledard,David Michonneau,Pauline Brice,Hélène Labussière-Wallet,Jean-David Bouaziz,Florent Grange,Hélène Moins-Teisserenc,Katayoun Jondeau,Laurence Michel,Samia Mourah,Maxime Battistella,Etienne Daguindau,Michael Loschi,Alexandra Picard,Nathalie Franck,Natacha Maillard,Anne Huynh,Stephanie Nguyen,Ambroise Marçais,G. Chaby,Patrice Ceballos,Yannick Le Corre,Sébastien Maury,Jacques-Olivier Bay,Henri Adamski,Emmanuel Bachy,Edouard Forcade,Gérard Socié,Martine Bagot,Sylvie Chevret,Régis Peffault de Latour +51 more
TL;DR: In this article , the authors investigated the effect of allogeneic haematopoietic stem cell transplantation (HSCT) compared with non-HSCT therapy on the outcome of individuals with advanced-stage CTCLs.
Journal ArticleDOI
Reply to M. Lambertini et al
Isabelle Demeestere,Pauline Brice,Fedro A. Peccatori,Alain Kentos,Jehan Dupuis,Pierre Zachee,Rene-Olivier Casasnovas,Eric Van Den Neste,Julie Dechene,Viviane De Maertelaer,Dominique Bron,Yvon Englert +11 more
Journal ArticleDOI
Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group
Danielle Canioni,Laure Joseph,Bettina Fabiani,Catherine Chassagne-Clément,Peggy Dartigues-Cuillères,Frédéric Charlotte,Pauline Brice,Pierre Feugier,Franck Morschhauser,Anne Sonet,Gilles Salles,Luc Xerri +11 more